Ionis Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
617.92 |
846.46 |
909.05 |
1,264.16 |
1,671.80 |
2,183.93 |
| Przychód Δ r/r |
0.00% |
36.99% |
7.39% |
39.06% |
32.25% |
30.63% |
| Przychód (min) |
596.04 |
757.87 |
618.52 |
1,251.16 |
1,404.09 |
1,834.21 |
| Przychód (max) |
672.82 |
941.69 |
1,347.99 |
1,277.16 |
2,084.80 |
2,723.45 |
| EBITDA (średnia) |
-185.63 |
-254.29 |
-273.09 |
-379.77 |
-502.22 |
-656.07 |
| EBIT (średnia) |
-200.05 |
-274.05 |
-294.31 |
-409.28 |
-541.25 |
-707.05 |
| EBIT % |
-32.38% |
-32.38% |
-32.38% |
-32.38% |
-32.38% |
-32.38% |
| Zysk netto (średni) |
-519.32 |
-408.07 |
-500.05 |
-259.47 |
35.99 |
409.29 |
| Zysk netto % |
-84.04% |
-48.21% |
-55.01% |
-20.52% |
2.15% |
18.74% |
| EPS (średnia) |
-3.50 |
-2.73 |
-3.10 |
-1.46 |
0.24 |
2.74 |
| Liczba analityków (Przychody) |
18 |
15 |
25 |
19 |
8 |
10 |
| Liczba analityków (EPS) |
13 |
10 |
17 |
16 |
15 |
14 |
| symbol |
IONS |
IONS |
IONS |
IONS |
IONS |
IONS |